Hypoxic Radiosensitization: Adored and Ignored

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24 · Cited by 4,519 · see citing works

Exploiting tumour hypoxia in cancer treatment

Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · see citing works

Hypoxia in cancer: significance and impact on clinical outcome

Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240 · see citing works

The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy

Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,228 · see citing works

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158 · see citing works

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.038 · Cited by 953 · see citing works

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

Nordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942 · see citing works

Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620 · see citing works

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. J. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 575 · see citing works

Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02

Rischin, D., Hicks, R. J., Fisher, R., Binns, D., Corry, J. F., Porceddu, S. V., & Peters, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2878 · Cited by 540 · see citing works

Hypoxic gene expression and metastasis

Le, Q., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 466 · see citing works

Chemical Radiosensitizers for Use in Radiotherapy

Wardman, P. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.010 · Cited by 452 · see citing works

Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers

Overgaard, J., & Horsman, M. R. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80032-4 · Cited by 420 · see citing works

Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment

Moeller, B. J., Richardson, R. A., & Dewhirst, M. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9056-0 · Cited by 417 · see citing works

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Kaanders, J. H. A. M., Wijffels, K. I. E. M., Marres, H. A. M., Ljungkvist, A. S. E., Pop, L. A. M., van den Hoogen, F. J. A., de Wilde, P. C. M., Bussink, J., Raleigh, J. A., & van der Kogel, A. J. (2002) · PubMed · Cited by 357 · see citing works

Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial

Koukourakis, M. I., Bentzen, S. M., Giatromanolaki, A., Wilson, G. D., Daley, F. M., Saunders, M. I., Dische, S., Sivridis, E., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7474 · Cited by 289 · see citing works

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial

Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274 · see citing works

ARCON: a novel biology-based approach in radiotherapy

Kaanders, J. H., Bussink, J., & van der Kogel, A. J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00929-4 · Cited by 257 · see citing works

Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)

Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253 · see citing works

The strengths and limitations of meta-analyses based on aggregate data

Lyman, G. H., & Kuderer, N. M. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-14 · Cited by 250 · see citing works

Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies

Horsman, M. R., & Siemann, D. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2848 · Cited by 248 · see citing works

Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.

Overgaard, J. (1994) · PubMed · Cited by 216 · see citing works

Oxygenation of Human Tumors

Vaupel, P. W., & Höckel, M. (2000) · Medical radiology · doi:10.1007/978-3-642-58813-6_6 · Cited by 189 · see citing works

Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix

Watson, E. R., Hainan, K. E., Dische, S., Saunders, M. I., Cade, I. S., McEwen, J. B., Wiernik, G., Perrins, D. J. D., & Sutherland, I. (1978) · British Journal of Radiology · doi:10.1259/0007-1285-51-611-879 · Cited by 187 · see citing works

Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the bladder

Cade, I. S., McEwen, J. B., Dische, S., Saunders, M. I., Watson, E. R., Halnan, K. E., Wiernik, G., Perrins, D. J. D., & Sutherland, I. (1978) · British Journal of Radiology · doi:10.1259/0007-1285-51-611-876 · Cited by 182 · see citing works

Chemical sensitizers for hypoxic cells: A decade of experience in clinical radiotherapy

Dische, S. (1985) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(85)80015-3 · Cited by 179 · see citing works

Sensitization of Hypoxic Tumour Cells—Clinical Experience

Overgaard, J. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914552081 · Cited by 154 · see citing works

Radiobiologic basis of oxygen as a modifying factor in radiation therapy.

Gray, L. H. (1961) · PubMed · Cited by 138 · see citing works

Nicotinamide and Other Benzamide Analogs as Agents for Overcoming Hypoxic Cell Radiation Resistance in Tumours

Horsman, M. R. (1995) · Acta Oncologica · doi:10.3109/02841869509094031 · Cited by 126 · see citing works

Hypoxia-imaging with 18F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer

Eschmann, S. M., Paulsen, F., Bedeshem, C., Machulla, H., Hehr, T., Bamberg, M., & Bares, R. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.014 · Cited by 118 · see citing works

Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

Bentzen, L., Keiding, S., Nordsmark, M., Falborg, L., Hansen, S. B., Keller, J. O., Nielsen, O. S., & Overgaard, J. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00081-1 · Cited by 117 · see citing works

Hyperbaric oxygenation for tumour sensitisation to radiotherapy

Bennett, M., Feldmeier, J., Smee, R., & Milross, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005007.pub3 · Cited by 109 · see citing works

The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: A prospective international multi-center study

Nordsmark, M., Loncaster, J. A., Aquino‐Parsons, C., Chou, S.-C., Gebski, V., West, C., Lindegaard, J. C., Havsteen, H., Davidson, S. E., Hunter, R. D., et al. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.010 · Cited by 103 · see citing works

The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON

Jonathan, R. A., Wijffels, K. I. E. M., Peeters, W. J. M., de Wilde, P. C. M., Marres, H. A. M., Merkx, M. A. W., Oosterwijk, E., van der Kogel, A. J., & Kaanders, J. H. A. M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.04.008 · Cited by 95 · see citing works

Clinical studies of hypoxia modification in radiotherapy

Kaanders, J. H. A. M., Bussink, J., & van der Kogel, A. J. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.002 · Cited by 91 · see citing works

Carbogen breathing during radiation therapy The radiation therapy oncology group study

Rubin, P., Hanley, J. A., Keys, H. M., Marcial, V. A., & Brady, L. W. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90946-5 · Cited by 90 · see citing works

Hypoxic cell sensitizers for radiotherapy

ADAMS, G. E. (1978) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(78)90129-3 · Cited by 88 · see citing works

Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients

Nordsmark, M., Eriksen, J. G., Gebski, V., Alsner, J., Horsman, M. R., & Overgaard, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.021 · Cited by 85 · see citing works

Results of a european randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

Eschwège, F., Sancho-Garnier, H., Chassagne, D., Brisgand, D., Guerra, M., Malaise, E. P., Bey, P., Busutti, L., Cionini, L., Nguyen, T. D., et al. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00327-1 · Cited by 81 · see citing works

A Model of Reoxygenation Dynamics of Head-And-Neck Tumors Based on Serial 18F-Fluoromisonidazole Positron Emission Tomography Investigations

Thorwarth, D., Eschmann, S. M., Paulsen, F., & Alber, M. L. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.037 · Cited by 79 · see citing works

Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

Saunders, M. I., & Dische, S. (1996) · PubMed · Cited by 70 · see citing works

Thirty years of medical research council randomized trials in solid tumours

Machin, D., Stenning, S. P., Parmar, M., Fayers, P. M., Girling, D. J., Stephens, R. J., Stewart, L. A., & Whaley, J. B. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(05)80448-0 · Cited by 64 · see citing works

Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis

Witham, T. F., Fukui, M. B., MELTZER, C. C., Burns, R., Kondziolka, D. S., & Bozik, M. E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991001)86:7 · Cited by 64 · see citing works

Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.

Hoskin, P., Saunders, M. I., & Dische, S. (1999) · PubMed · Cited by 59 · see citing works

Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review

Newbold, K. L., Partridge, M., Cook, G., Sohaib, S. A., Charles-Edwards, E., Rhys‐Evans, P., Harrington, K. J., & Nutting, C. M. (2006) · British Journal of Radiology · doi:10.1259/bjr/48822193 · Cited by 59 · see citing works

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study

Eriksen, J. G., & Overgaard, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.009 · Cited by 58 · see citing works

Hyperbaric oxygenation for tumour sensitisation to radiotherapy

Bennett, M., Feldmeier, J., Smee, R., & Milross, C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005007.pub2 · Cited by 48 · see citing works

AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: Results of an IAEA multicentre randomised trial

Dobrowsky, W., Huigol, N., Jayatilake, R., Kizilbash, N.-I.-A., Okkan, S., Kagiya, V. T., & Tatsuzaki, H. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.11.007 · Cited by 47 · see citing works

Evolution of the radiation therapy oncology group clinical trials for head and neck cancer

Fu, K. K., Cooper, J. S., Marcial, V. A., Laramore, G. E., Pajak, T. F., Jacobs, J., Al‐Sarraf, M., Forastiere, A. A., & Cox, J. D. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)80003-4 · Cited by 46 · see citing works

Individual Patient- versus Literature-Based Meta-analysis of Survival Data

Duchateau, L., Pignon, J., Bijnens, L., Bertin, S., Bourhis, J., & Sylvester, R. J. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00152-0 · Cited by 44 · see citing works

Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial

Dische, S., Saunders, M. I., Sealy, R., Werner, I. D., Verma, N., Foy, C. J. W., & Bentzen, S. M. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00124-3 · Cited by 43 · see citing works

The Influence of Radiation Dose on the Magnitude and Kinetics of Reoxygenation in a C3H Mammary Carcinoma

Grau, C., & Overgaard, J. (1990) · Radiation Research · doi:10.2307/3577761 · Cited by 34 · see citing works

Hyperbaric oxygen in radiation therapy

Glassburn, J. R., Brady, L. W., & Plenk, H. P. (1977) · Cancer · doi:10.1002/1097-0142(197702)39:2+ · Cited by 32 · see citing works

Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck

Mendenhall, W. M., Morris, C. G., Amdur, R. J., Mendenhall, N. P., & Siemann, D. W. (2005) · Cancer · doi:10.1002/cncr.21146 · Cited by 31 · see citing works

Phase III Trial of Radiosensitizer PR-350 Combined With Intraoperative Radiotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Sunamura, M., Karasawa, K., Okamoto, A., Ogata, Y., Nemoto, K., Hosotani, R., Nishimura, Y., Matsui, K., & Matsuno, S. (2004) · Pancreas · doi:10.1097/00006676-200404000-00023 · Cited by 28 · see citing works

The Oxygen Effect in Radiotherapy � Historical Review

Churchill‐Davidson, I. (2015) · Frontiers of radiation therapy and oncology · doi:10.1159/000386946 · Cited by 27 · see citing works

An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers

Huilgol, N., Chatterjee, N., & Mehta, A. R. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02181-7 · Cited by 27 · see citing works

A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer

Chan, P., Milosevic, M., Fyles, A., Carson, J., Pintilie, M., Rauth, A. M., & Thomas, G. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2003.11.018 · Cited by 24 · see citing works

Meta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma.

Huncharek, M. S. (1998) · PubMed · Cited by 24 · see citing works

Hypoxic Cell Sensitizers for Radiotherapy

ADAMS, G. E. (1977) · Springer eBooks · doi:10.1007/978-1-4684-2739-4_6 · Cited by 15 · see citing works

A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long term results.

Okkan, S., Atkovar, G., Şahinler, İ., Turkan, S., & Uzel, R. (1996) · Europe PMC (PubMed Central) · Cited by 11 · see citing works

Local tumour control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy: a meta-analysis

Dayes, I. S., & Abuzallouf, S. (2005) · British Journal of Radiology · doi:10.1259/bjr/57750595 · Cited by 11 · see citing works

Safety and radiosensitizing efficacy of sanazole (AK 2123) in oropharyngeal cancers: Randomized controlled double blind clinical trial

Ullal, S., Kr, S., Pai, M., Chowta, M. N., Adiga, S., Dinesh, M. G., Kamath, A., Kotian, M., & Pai, D. (2006) · Indian Journal of Cancer · doi:10.4103/0019-509x.29419 · Cited by 9 · see citing works

Normobaric oxygen treatment during radiotherapy for carcinoma of the uterine cervix. Results from a prospective controlled randomized trial

Sundfør, K., Tropé, C. G., Suo, Z., & Bergsjø, P. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00142-x · Cited by 9 · see citing works

Use of ornidazole in fractionated radiotherapy: Dose tolerance, serum and tumour tissue concentration

Okkan, S., Yazıcı, Z., Uzel, R., Akçasu, A., Türkan, S., Hacibekirolu, M., Olgun, P., & Egehan, Î. (1986) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(86)80178-5 · Cited by 8 · see citing works

Clinical Experience with Intravenous Misonidazole for Carcinoma of the Esophagus: Results in Attempting Radiosensitization of Each Fraction of Exposure

Schwade, J. G., Kinsella, T. J., Kelly, B. A., Rowland, J., Johnston, M. R., & GLATSTEIN, E. J. (1984) · Cancer Investigation · doi:10.3109/07357908409020291 · Cited by 8 · see citing works

Practicality of Hemodynamic Monitoring

Urtasun, R. C., Band, P. R., Chapman, J. D., & Feldstein, M. L. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961315 · Cited by 8 · see citing works

Radiation plus Metronidazole for Glioblastoma

(1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961316 · Cited by 5 · see citing works

Clinical trial of atmospheric oxygen breathing during radiotherapy for cancer of the oropharynx.

Jc, E., & Pj, C. (1975) · PubMed · Cited by 4 · see citing works

Oxygen tension of oral cavity carcinoma.

Jc, E., & Lj, S. (1970) · PubMed · Cited by 4 · see citing works

[Comparison of the effectiveness of different methods of irradiation using metronidazole as a radiation-sensitizing agent in patients with laryngeal cancer. Controlled clinical studies].

Gałecki, J., Dukowicz, A., Hliniak, A., Mierzwińska, J., Mykowiecka, A., Osiadacz, W., Prejbisz, J., & Hipsz, K. (1989) · PubMed · Cited by 3 · see citing works

The impact of O2 availability on human cancer

Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365 · see citing works

Hypoxia, DNA repair and genetic instability

Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140 · see citing works

Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response

McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050 · see citing works

Exploring the role of cancer stem cells in radioresistance

Baumann, M. A., Krause, M., & Hill, R. P. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2419 · Cited by 817 · see citing works

Imaging hypoxia to improve radiotherapy outcome

Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614 · see citing works

Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck

Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S. J., Tramm, T., Alsner, J., & Overgaard, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2853 · Cited by 611 · see citing works

Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer

Juzenas, P., Chen, W., Sun, Y.-P., Coelho, M. A. N., Generalov, R., Generalova, N., & Christensen, I. L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.004 · Cited by 610 · see citing works

Molecular mechanisms of tumor resistance to radiotherapy

Wu, Y., Song, Y., Wang, R., & Wang, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01801-2 · Cited by 539 · see citing works

Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise

Rockwell, S., Dobrucki, I. T., Kim, E. Y., Marrison, S. T., & Vu, V. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167087 · Cited by 512 · see citing works

Strategies for optimizing the response of cancer and normal tissues to radiation

Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4003 · Cited by 461 · see citing works

Hypoxia: an alarm signal during intestinal inflammation

Colgan, S. P., & Taylor, C. T. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.39 · Cited by 461 · see citing works

Hypoxic Modification of Radiotherapy in Squamous Cell Carcinoma of the Head and Neck - A Systematic Review and Meta-Analysis

Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.03.004 · Cited by 456 · see citing works

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation

Hellevik, T., & Martínez-Zubiaurre, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00001 · Cited by 442 · see citing works

A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms

Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 396 · see citing works

Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy

Meijer, T. W. H., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0858 · Cited by 433 · see citing works

Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response

Zannella, V. E., Pra, A. D., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J. R., Glicksman, R., Chaib, S., Zamiara, P., Milosevic, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1787 · Cited by 315 · see citing works

Proton vs carbon ion beams in the definitive radiation treatment of cancer patients

Suit, H. D., DeLaney, T. F., Goldberg, S. N., Paganetti, H., Clasie, B., Gerweck, L. E., Niemierko, A., Hall, E. J., Flanz, J. B., Hallman, J., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.015 · Cited by 293 · see citing works

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

Traber, G. M., & Yu, A. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 301 · see citing works

Up-down regulation of HIF-1α in cancer progression

Rashid, M., Zadeh, L. R., Baradaran, B., Molavi, O., Ghesmati, Z., Sabzichi, M., & Ramezani, F. (2021) · Gene · doi:10.1016/j.gene.2021.145796 · Cited by 291 · see citing works

Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome

Salem, A., Asselin, M., Reymen, B. J. T., Jackson, A., Lambin, P., West, C., O’Connor, J. P. B., & Finn, C. F. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx160 · Cited by 267 · see citing works

Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms

Sinha, D., Sarkar, N., Biswas, J., & Bishayee, A. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.11.001 · Cited by 262 · see citing works

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial

Janssens, G. O. R. J., Rademakers, S. E., Terhaard, C. H. J., Doornaert, P., Bijl, H. P., van den Ende, P. L. A., Chin, A., Marres, H. A. M., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 259 · see citing works

Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer

Toustrup, K., Sørensen, B. S., Nordsmark, M., Busk, M., Wiuf, C., Alsner, J., & Overgaard, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1182 · Cited by 259 · see citing works

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

Dubrovska, A., Cojoc, M., Peitzsch, C., Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 255 · see citing works

Cancer stem cells and radioresistance

Rycaj, K., & Tang, D. G. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892227 · Cited by 255 · see citing works

Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications

Tataranni, T., & Piccoli, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8201079 · Cited by 251 · see citing works

Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy

Kim, B. M., Hong, Y., Lee, S., Liu, P., Lim, J. Y., Lee, Y. C., Lee, T., Chang, K. T., & Hong, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125991 · Cited by 235 · see citing works

Tumor hypoxia as a driving force in genetic instability

Luoto, K. R., Kumareswaran, R., & Bristow, R. G. (2013) · Genome Integrity · doi:10.1186/2041-9414-4-5 · Cited by 222 · see citing works

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

Toustrup, K., Sørensen, B. S., Lassen, P., Wiuf, C., Alsner, J., & Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.09.010 · Cited by 221 · see citing works

Multiparametric Imaging of Tumor Response to Therapy

Padhani, A. R., & Miles, K. A. (2010) · Radiology · doi:10.1148/radiol.10091760 · Cited by 219 · see citing works

The Role of Cancer Stem Cells in Radiation Resistance

Arnold, C. R., Mangesius, J., Skvortsova, I., & Ganswindt, U. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00164 · Cited by 214 · see citing works

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S. J., Tramm, T., Alsner, J., & Overgaard, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.10.008 · Cited by 210 · see citing works

Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?

Wang, H., Jiang, H., Gucht, M. V. D., & Ridder, M. D. (2019) · Cancers · doi:10.3390/cancers11010112 · Cited by 206 · see citing works

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Ansari, M. J., Bokov, D., Markov, A., Jalil, A. T., Shalaby, M. N., Suksatan, W., Chupradit, S., AL-Ghamdi, H. S., Shomali, N., Zamani, A., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00838-y · Cited by 197 · see citing works

Clinical update on cancer: molecular oncology of head and neck cancer

Suh, Y., Amelio, I., Urbano, T. G., & Tavassoli, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.548 · Cited by 189 · see citing works

The Clinical Significance of Hypoxia in Human Cancers

Dhani, N. C., Fyles, A., Hedley, D. W., & Milosevic, M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.11.002 · Cited by 189 · see citing works

Interfering with Tumor Hypoxia for Radiotherapy Optimization

Telarović, I., Wenger, R. H., & Pruschy, M. N. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02000-x · Cited by 196 · see citing works

Radiation chemistry comes before radiation biology

O’Neill, P., & Wardman, P. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000802640401 · Cited by 179 · see citing works

Molecular targeting of hypoxia in radiotherapy

Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 171 · see citing works

Kill-painting of hypoxic tumours in charged particle therapy

Tinganelli, W., Durante, M., Hirayama, R., Krämer, M., Maier, A., Kraft-Weyrather, W., Furusawa, Y., Friedrich, T., & Scifoni, E. (2015) · Scientific Reports · doi:10.1038/srep17016 · Cited by 164 · see citing works

Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?

Cui, L., Her, S., Borst, G. R., Bristow, R. G., Jaffray, D. A., & Allen, C. J. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.007 · Cited by 163 · see citing works

The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules

Arnold, K. M., Flynn, N. J., Raben, A., Romak, L. B., Yu, Y., Dicker, A. P., Mourtada, F., & Sims‐Mourtada, J. (2018) · Cancer Growth and Metastasis · doi:10.1177/1179064418761639 · Cited by 167 · see citing works

Dose- and LET-painting with particle therapy

Bassler, N., Jäkel, O., Søndergaard, C. S., & Petersen, J. B. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.510640 · Cited by 158 · see citing works

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

Lassen, P. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.04.022 · Cited by 157 · see citing works

Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery

Stapleton, S., Jaffray, D. A., & Milosevic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.021 · Cited by 153 · see citing works

Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy

Dunne, M., Regenold, M., & Allen, C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.007 · Cited by 150 · see citing works

Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy

Zhang, C., Yan, L., Gu, Z., & Zhao, Y. (2019) · Chemical Science · doi:10.1039/c9sc02107h · Cited by 146 · see citing works

Imaging Heterogeneity in Lung Cancer: Techniques, Applications, and Challenges

Bashir, U., Siddique, M. M., McLean, E., Goh, V., & Cook, G. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15864 · Cited by 142 · see citing works

Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy

Mistry, I. N., Thomas, M., Calder, E. D. D., Conway, S. J., & Hammond, E. M. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.024 · Cited by 143 · see citing works

Hypoxia as a biomarker for radioresistant cancer stem cells

Peitzsch, C., Perrin, R. L., Hill, R. P., Dubrovska, A., & Kurth, I. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.916841 · Cited by 142 · see citing works

Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy

Hua, L., Wang, Z., Zhao, L., Mao, H., Wang, G., Zhang, K., Liu, X., Wu, D., Zheng, Y., Lu, J. L., et al. (2018) · Theranostics · doi:10.7150/thno.26225 · Cited by 142 · see citing works

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Linge, A., Lohaus, F., Löck, S., Nowak, A., Gudziol, V., Valentini, C., von Neubeck, C., Jütz, M., Tinhofer, I., Budach, V., et al. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.11.008 · Cited by 141 · see citing works

Transition metal compounds as cancer radiosensitizers

Gill, M. R., & Vallis, K. A. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00641e · Cited by 139 · see citing works

Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation

McGee, M. C., Hamner, J. B., Williams, R. F., Rosati, S. F., Sims, T. L., Ng, C. Y., Gaber, M. W., Calabrese, C. R., Wu, J., Nathwani, A. C., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.010 · Cited by 137 · see citing works

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours

Bigos, K. J. A., Quiles, C. G., Lunj, S., Smith, D. J., Krause, M., Troost, E. G. C., West, C., Hoskin, P., & Choudhury, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1331355 · Cited by 142 · see citing works

PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells

Palayoor, S. T., Mitchell, J. B., Cerna, D., DeGraff, W., John‐Aryankalayil, M., & Coleman, C. N. (2008) · International Journal of Cancer · doi:10.1002/ijc.23807 · Cited by 132 · see citing works

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

Linge, A., Löck, S., Gudziol, V., Nowak, A., Lohaus, F., von Neubeck, C., Jütz, M., Abdollahi, A., Debus, J., Tinhofer, I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1990 · Cited by 132 · see citing works

Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial

Overgaard, J., Mohanti, B. K., Begum, N., Ali, R., Agarwal, J. P., Kuddu, M., Bhasker, S., Tatsuzaki, H., & Grau, C. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70072-3 · Cited by 131 · see citing works

Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study

Véra, P., Bohn, P., Edet‐Sanson, A., Salles, A., Hapdey, S., Gardin, I., Ménard, J.-F., Modzelewski, R., Thiberville, L., & Dubray, B. M. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.10.011 · Cited by 127 · see citing works

Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy

Cerniglia, G. J., Pore, N., Tsai, J. H., Schultz, S. M., Mick, R., Choe, R., Xing, X., Durduran, T., Yodh, A. G., Evans, S. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006539 · Cited by 125 · see citing works

Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma

Liu, H., Xie, Y., Zhang, Y., Cai, Y., Li, B., Mao, H., Liu, Y., Lu, J. L., Zhang, L., & Yu, R. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.001 · Cited by 122 · see citing works

A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy

Tang, W., Yáng, Z., He, L., Deng, L., Fathi, P., Zhu, S., Li, L., Shen, B., Wang, Z., Jacobson, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20860-3 · Cited by 122 · see citing works

Adenosine and Hypoxia-Inducible Factor Signaling in Intestinal Injury and Recovery

Colgan, S. P., & Eltzschig, H. K. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153230 · Cited by 121 · see citing works

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology

Bristow, R. G., Alexander, B. M., Baumann, M. A., Bratman, S. V., Brown, J. M., Camphausen, K. A., Choyke, P. L., Citrin, D. E., Contessa, J. N., Dicker, A. P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30096-2 · Cited by 121 · see citing works

Therapeutic targeting of the prostate cancer microenvironment

Κάρλου, Μ., Tzelepi, V., & Efstathiou, E. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.134 · Cited by 119 · see citing works

Hypoxia signaling in cancer: Implications for therapeutic interventions

Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119 · see citing works

The relevance of a hypoxic tumour microenvironment in prostate cancer

Stewart, G. D., Ross, J. A., McLaren, D. B., Parker, C. C., Habib, F. K., & Riddick, A. C. P. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08921.x · Cited by 116 · see citing works

PET-CT for response assessment and treatment adaptation in head and neck cancer

Bussink, J., van Herpen, C. M. L., Kaanders, J. H. A. M., & Oyen, W. J. G. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70353-5 · Cited by 111 · see citing works

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials

Spiegelberg, L., Houben, R. M. A., Niemans, R., Ruysscher, D. D., Yaromina, A., Theys, J., Guise, C. P., Smaill, J. B., Patterson, A. V., Lambin, P., et al. (2019) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2019.01.005 · Cited by 113 · see citing works

Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation

Klein, C., Đokić, I., Mairani, A., Mein, S., Brons, S., Bolívar, P. H., Haberer, T., Jäkel, O., Zimmermann, A., Zenke, F. T., et al. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0939-0 · Cited by 110 · see citing works

Hyperbaric oxygenation for tumour sensitisation to radiotherapy

Bennett, M., Feldmeier, J., Smee, R., & Milross, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005007.pub3 · Cited by 109 · see citing works

Oxygen-Guided Radiation Therapy

Epel, B., Maggio, M. C., Barth, E. D., Miller, R. C., Pelizzari, C. A., Krzykawska-Serda, M., Sundramoorthy, S. V., Aydogan, B., Weichselbaum, R. R., Tormyshev, V. M., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.10.041 · Cited by 107 · see citing works

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

Lü, Z., Shen, J., Yang, H. J., Wang, J., Zhao, R., Zhang, T.-L., Guo, J. R., & Zhang, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01298-z · Cited by 108 · see citing works

Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions

Jain, S., Coulter, J. A., Butterworth, K. T., Hounsell, A. R., McMahon, S. J., Hyland, W. B., Muir, M. F., Dickson, G. R., Prise, K. M., Currell, F. J., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.12.013 · Cited by 107 · see citing works

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Goedegebuure, R. S. A., de Klerk, L. K., Bass, A. J., Sarah Derks, A., & Thijssen, V. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03107 · Cited by 108 · see citing works

Combining radiotherapy with immunotherapy: the past, the present and the future

Limbergen, E. J. V., Ruysscher, D. D., Pimentel, V. O., Marcus, D., Berbée, M., Hoeben, A., Rekers, N. H., Theys, J., Yaromina, A., Dubois, L. J., et al. (2017) · British Journal of Radiology · doi:10.1259/bjr.20170157 · Cited by 105 · see citing works

Targeting Tumor Perfusion and Oxygenation to Improve the Outcome of Anticancer Therapy1

Jordan, B. F., & Sonveaux, P. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00094 · Cited by 104 · see citing works

Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy

Koritzinsky, M. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.003 · Cited by 101 · see citing works

Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspective

Koch, U., Krause, M., & Baumann, M. A. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.003 · Cited by 102 · see citing works

mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity

Dash, R., Bhutia, S. K., Azab, B., Su, Z.-Z., Quinn, B. A., Kegelmen, T. P., Das, S. K., Kim, K., Lee, S., Park, M. A., et al. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.08.004 · Cited by 102 · see citing works

Dose prescription and treatment planning based on FMISO-PET hypoxia

Toma-Daşu, I., Uhrdin, J., Antonovic, L., Daşu, A., Nuyts, S., Dirix, P. R., Haustermans, K. M., & Brahme, A. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.599815 · Cited by 102 · see citing works

Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings

Fraga, A. M., Ribeiro, R. J. T., Príncipe, P., Lopes, C., & Medeiros, R. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.03.006 · Cited by 101 · see citing works

Radioresistance of glioma stem cells: Intrinsic characteristic or property of the ‘microenvironment‐stem cell unit’?

Mannino, M., & Chalmers, A. J. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.05.001 · Cited by 96 · see citing works

The importance of radiation chemistry to radiation and free radical biology (The 2008 Silvanus Thompson Memorial Lecture)

Wardman, P. (2009) · British Journal of Radiology · doi:10.1259/bjr/60186130 · Cited by 98 · see citing works

Hypoxia-Induced Resistance to Chemotherapy in Cancer

Minassian, L. M., Cotechini, T., Huitema, E., & Graham, C. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_9 · Cited by 99 · see citing works

All‐In‐One Biomimetic Nanoplatform Based on Hollow Polydopamine Nanoparticles for Synergistically Enhanced Radiotherapy of Colon Cancer

Gong, L., Zhang, Y., Zhao, J., Zhang, Y., Tu, K., Jiao, L., Xu, Q., Zhang, M., & Han, S. (2022) · Small · doi:10.1002/smll.202107656 · Cited by 97 · see citing works

Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings

Colliez, F., Gallez, B., & Jordan, B. F. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00010 · Cited by 96 · see citing works

Overexpression of Intrinsic Hypoxia Markers HIF1α and CA-IX Predict for Local Recurrence in Stage T1-T2 Glottic Laryngeal Carcinoma Treated With Radiotherapy

Schrijvers, M. L., van der Laan, B. F. A. M., de Bock, G. H., Pattje, W. J., Mastik, M. F., Menkema, L., Langendijk, J. A., Kluin, P. M., Schuuring, E. M. D., & van der Wal, J. E. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.025 · Cited by 96 · see citing works

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy

Liu, H., Zhang, Y., Xie, Y., Cai, Y., Baiyang, L., Li, W. J., Zeng, L.-Y., Li, Y., & Yu, R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125286 · Cited by 94 · see citing works

Hypoxia Mediates Tumor Malignancy and Therapy Resistance

Luo, W., & Wang, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_1 · Cited by 93 · see citing works

Trial Watch

Vacchelli, E., Vitale, I., Tartour, É., Eggermont, A. M. M., Sautès‐Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.25595 · Cited by 91 · see citing works

18F-Fluoromisonidazole in tumor hypoxia imaging

Xu, Z., Li, X., Zou, H., Sun, X., & Shen, B. (2017) · Oncotarget · doi:10.18632/oncotarget.21662 · Cited by 91 · see citing works

PET–CT for radiotherapy treatment planning and response monitoring in solid tumors

Bussink, J., Kaanders, J. H. A. M., van der Graaf, W. T. A., & Oyen, W. J. G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.218 · Cited by 89 · see citing works

Targeting the DNA damage response for cancer therapy

Powell, S. N., & Bindra, R. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.011 · Cited by 86 · see citing works

Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score

Stewart, G. D. (1994) · Oncology Reports · doi:10.3892/or_00000180 · Cited by 89 · see citing works

Functional Imaging for Radiation Treatment Planning, Response Assessment, and Adaptive Therapy in Head and Neck Cancer

Bhatnagar, P., Subesinghe, M., Patel, C., Prestwich, R. J. D., & Scarsbrook, A. F. (2013) · Radiographics · doi:10.1148/rg.337125163 · Cited by 88 · see citing works

Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation

Yaromina, A., Thames, H. D., Zhou, X., Hering, S., Eicheler, W., Dörfler, A., Leichtner, T., Zips, D., & Baumann, M. A. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.04.020 · Cited by 88 · see citing works

Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers

Oronsky, B. T., Knox, S. J., & Scicinski, J. J. (2011) · Translational Oncology · doi:10.1593/tlo.11166 · Cited by 89 · see citing works

Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non–small Cell Lung Cancer

Salem, A., Little, R. A., Latif, A., Featherstone, A. K., Babur, M., Peset, I., Cheung, S., Watson, Y., Tessyman, V., Mistry, H. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3932 · Cited by 87 · see citing works

Multistage-responsive clustered nanosystem to improve tumor accumulation and penetration for photothermal/enhanced radiation synergistic therapy

Hua, S., He, J., Zhang, F., Yu, J., Zhang, W., Gao, L., Li, Y., & Zhou, M. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120590 · Cited by 86 · see citing works

Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers

Overgaard, J., & Horsman, M. R. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80032-4 · Cited by 420 · see citing works

The impact of hypoxia and its modification of the outcome of radiotherapy

Horsman, M. R., & Overgaard, J. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw007 · Cited by 313 · see citing works

Therapeutic Modification of Hypoxia

Horsman, M. R., Sørensen, B. S., Busk, M., & Siemann, D. W. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.08.014 · Cited by 39 · see citing works

Tumor Hypoxia

Nordsmark, M., Busk, M., Petersen, J. B. B., Alsner, J., Overgaard, J., & Horsman, M. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-53632-7.00903-5

RSU 1069, a nitroimidazole containing an aziridine group

Stratford, I. J., O’Neill, P., SHELDON, P. W., Silver, A. R., Walling, J. M., & ADAMS, G. E. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90566-6 · Cited by 103 · see citing works